Alectinib for the treatment of ALK-positive stage IV non-small cell lung cancer.
K. M. Wong, Tomas S. Noonan, C O'Bryant, Antonio Jimeno
págs. 161-170
Golimumab: clinical update on its use for ulcerative colitis.
D Gilardi, G Fiorino, M. Allocca, I. Bravata, S. Danese
págs. 171-184
First fixed-ratio combination of insulin degludec and liraglutide for the treatment of type 2 diabetes.
H.M. Rendell
págs. 185-196
Terbinafine: novel formulations that potentiate antifungal activities.
Brigette B.Y. Ma, C. X. Chen, S. Guan
págs. 197-208
A report from the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 (February 23-26 – Seattle, Washington, USA).
Xavier Rabasseda
págs. 209-216
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: